Quantcast
Monday, September 14, 2020
blank

AstraZeneca exits cancer center business

AstraZeneca  has completed the previously disclosed  sale of the assets of its subsidiary, Aptium Oncology. Aptium Oncology provided outpatient oncology management and consulting services in the US, managing outpatient cancer centers in affiliation with five...
blank

A new look for the website

You might have noticed that this humble website has a new look.  The credit goes to New WordPress Themes http://newwpthemes.com. The company has rolled out themes that use the latest trends in news website design. The one...
blank

Bristol-Myers Squibb, AstraZeneca expand diabetes alliance

Bristol-Myers Squibb and AstraZeneca announced that, following the completion of Bristol-Myers Squibb’s acquisition of Amylin, the companies will enter into collaboration arrangements, regarding the development and  commercialization  of Amylin’s product line. Following Bristol-Myers Squibb’s acquisition...
blank

Wilmington-area lab expands services

SL Pharma Labs announced an expansion of its services to include quality control analytical and microbiological support for marketed pharmaceutical products. “Global pharmaceutical companies are looking for CRO partners that can provide focused expertise in...
blank

AstraZeneca completes $1.26 billion acquisition of Ardea

AstraZeneca has completed its $1.26 billion acquisition of San Diego-based drug development company, Ardea Biosciences, Inc. The merger was approved by Ardea’s stockholders. Each outstanding share of Ardea common stock was canceled and converted into...
blank

AstraZeneca, Rigel sign deal for potential new treatment for chronic asthma

AstraZeneca and Rigel Pharmaceuticals Inc. Tuesday  announced an  agreement for the global development and commercialization for a drug  now being investigated as a treatment for moderate to severe chronic asthma. AstraZeneca has headquarters and...
blank

Microsoft tablet computer aimed at taking on IPad – Bloomberg

Microsoft Corp. unveiled its own Windows-powered tablet computer called Surface, altering its strategy of focusing on software and relying on partners to make the machines in a renewed attempt to take on the Apple...
blank

Newark-based iBio makes progress on patent

The U.S. Patent Office has accepted a patent application for the iBio Inc. iBioModulator platform. The platform aims to improve the potency and effectiveness of vaccines used to fight flu, anthrax and other diseases...
blank

AstraZeneca among pharma companies seeking antibiotics answers

   A growing worry in medicine is bugs’ increasing resistance to antibiotics. At AstraZeneca’s research centre near Boston, scientists toil to find new weapons. Machines screen thousands of drugs each year, robotic arms nimbly handling...
blank

DuPont opens new office building

DuPont last week opened a new five-story, 220,000 square foot office building at its Chestnut Run facility – incorporating sustainability into the building design and using more than 20 DuPont innovations. The building is...